Clinical trial

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

NCT02756819

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Azilsartan Medoxomil Normalized identity: azilsartan medoxomilView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-07-18

PhaseN/A

Conditions

Hypertensionunresolved

Interventions

Azilsartan MedoxomilDRUG · verified · RxNorm: azilsartan medoxomil

Sponsors & collaborators

Takedalead sponsor

Mapped research locations

MoscowRussia7 Saint PetersburgRussia4 SaratovRussia2 YaroslavlRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02756819 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.